Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hodgkin Disease × Goserelin × Clear all

Sponsor

Conditions

Prostatic Neoplasms 50 Breast Neoplasms 25 Neoplasms 6 Neoplasm Metastasis 3 Prostate Adenocarcinoma 2 Breast Neoplasms, Male 2 Recurrence 1 Primary Ovarian Insufficiency 1 PSA Level Greater Than Two 1 Osteitis Deformans 1 Lymphatic Metastasis 1 Infertility 1 Hormone-sensitive Metastatic Breast Cancer 1 Hereditary Sensory and Autonomic Neuropathies 1 Advanced Metastatic Breast Cancer 1 Advanced Breast Cancer 1

Interventions

Cyclophosphamide 81 fludarabine phosphate 68 Mycophenolic Acid 57 Whole-Body Irradiation 51 Peripheral Blood Stem Cell Transplantation 51 Tacrolimus 49 Melphalan 44 Etoposide 42 Busulfan 39 fludarabine 36 Rituximab 36 Filgrastim 35 Granulocyte Colony-Stimulating Factor 34 Brentuximab Vedotin 31 Cyclosporine 30 Methotrexate 27 Doxorubicin 27 Antilymphocyte Serum 27 Radiotherapy 24 Dacarbazine 18 Cytarabine 18 Vinblastine 17 Nivolumab 17 Prednisone 16 Carmustine 16 thymoglobulin 15 Stem Cell Transplantation 15 Sirolimus 14 Alemtuzumab 14 Vincristine 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡